Before we introduce our next major feature release, here is a collection of small but helpful changes to CDD.
      
      
    Escape from the Dose-Response Thicket
When a compound has been assayed many times, its dose-response plot can become an impenetrable thicket of curves. As of this release we only show the curves that match your search criteria. For example, if you specify that the IC50 must be < 10 μM or the curve class must be < 2, only those curves will be shown on the plot. You can always revert to showing all curves by choosing "All" for "Displayed readouts" in the display options.
Auto-populated Fields
When creating a new batch, we now pre-populate the batch person field with your full name and the date field with today's date.Dearomatized Structures
Structures are now presented in dearomatized form throughout the application. This includes the SMILES and CXSMILES shown on the molecule page, in searches, and in exports.Other posts you might be interested in
View All Posts
    
      
        
        
          
          
      
        
        
          
          
            
              
                CDD Blog
              
            
              
            
          
      
    
  
  
   
  
 1 min
 
 October 29, 2025
  
  Book Testimonials for "Inside CDD Vault, A Different Kind of Silicon Valley Success Story"
  
  Read More
  
    
      
        
        
          
          
            
              
                CDD Blog
              
            
          
      
    
  
  
   
 3 min
 
 October 29, 2025
  
  HotHouse Therapeutics Implements CDD Vault To Accelerate Plant-Inspired Drug Discovery
  
  Read More
  
    
      
        
        
          
          
      
        
        
          
          
            
              
                Webinars
              
            
              
            
          
      
    
  
  
   
  
 1 min
 
 October 28, 2025
  
  ExpansionRx–OpenADMET Blind Challenge: Webinar Recap and How to Participate
  
  Read More
  
      
